Diagnostic accuracy of parkinson disease by support vector machine (SVM) analysis of 123I-FP-CIT brain SPECT data

Medicine (United States)

Volumn 93, Issue 27, 2014, Pages

  Palumbo, Barbara ^a   Fravolini, Mario Luca ^a   Buresta, Tommaso ^a   Pompili, Filippo ^a   Forini, Nevio ^a   Nigro, Pasquale ^a   Calabresi, Paolo ^a,b   Tambasco, Nicola ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IOFLUPANE I 123; POTASSIUM PERCHLORATE;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN SCINTISCANNING; CAUDATE NUCLEUS; CLASSIFICATION ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; ESSENTIAL TREMOR; FEMALE; FOLLOW UP; GAMMA CAMERA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONISM; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPPORT VECTOR MACHINE; VERY ELDERLY;

EID: 84919338839     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000228     Document Type: Article

References (23)

1. Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version. Eur J Nucl Med Mol Imaging. 2010; 37: 443-450.
2. Palumbo B, Fravolini ML, Nuvoli S, et al. Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT. Eur J Nucl Med Mol Imaging. 2010; 37: 2146-2153.
3. Schillaci O, Chiaravalloti A, Pierantozzi M, et al. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT. Int J Mol Med. 2011; 28: 881-886.
4. Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012; 53: 154-163.
5. Calvini P, Rodriguez G, Inguglia F, et al. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging. 2007; 34: 1240-1253.
6. Nobili F, Naseri M, De Carli F, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scansion healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2013; 40: 565-573.
7. Haller S, Badoud S, Nguyen D, et al. Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results. AJNR Am J Neuroradiol. 2012; 33: 2123-2128.
8. Chang CC, Lin CJ. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol. 2011; 2: 27: 127: 27.
9. Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995; 20: 273-297.
10. Shawe-Taylor J, Bartlett PL. Structural risk minimization over datadependent hierarchies. IEEE Trans Inf Theory. 1998; 44: 1926-1940.
11. Prashanth R, Dutta Roy S, Mandal PK, Ghosh S. Automatic classification and prediction models for early Parkinson's disease diagnosis from SPECT imaging. Expert Syst Appl. 2014; 41: 3333-3342.
12. Marek K, Jennings D, Lasch S, et al. The Parkinson progression marker initiative (PPMI). Prog Neurobiol. 2011; 95: 629-635.
13. Hoehn M, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967; 17: 427-442.
14. Fahn S, Elton RL. UPDRS Program Members. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Development in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-163.
15. Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998; 39: 1521-1530.
16. Rinne JO, Sahlberg N, Ruottinen H, et al. Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology. 1998; 50: 152-156.
17. Ishibashi K, Ishii K, Oda K, et al. Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum. Synapse. 2009; 63: 282-290.
18. van Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry. 2002; 10: 36-43.
19. Koch W, Pogarell O, Pöpperl G, et al. Extended studies of the striatal uptake of 99mTc-NC100697 in healthy volunteers. J Nucl Med. 2007; 48: 27-34.
20. Hamilton D, List A, Butler T, et al. Discrimination between Parkinsonian syndrome and essential tremor using artificial network classification of quantified DaTSCAN data. Nucl Med Commun. 2006; 27: 939-944.
21. Palumbo B, Fravolini ML. To what extent can artificial neural network support nuclear medicine? Hell J Nucl Med. 2012; 15: 180-183.
22. Punwani S, Taylor SA, Saad ZZ, et al. Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging. 2013; 40: 373-385.
23. Hashimoto J, Ogawa K, Bai J, et al. Simultaneous dual-isotope imaging based on an artificial neural network for evaluating myocardial perfusion and fatty acid metabolism. J Nucl Cardiol. 2013; 20: 396-405.